Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAdvice for n-of-1 Drug Developers.AuthorsJaklevic, Mary ChrisAbstractThe article reports on the clinical trial recommendations issued by the U.S. Food and Drug Administration (FDA) to antisense oligonucleotide (ASO) drug developers.PublicationJAMA: Journal of the American Medical Association, 2021, Vol 325, Issue 7, p613ISSN0098-7484Publication typeArticleDOI10.1001/jama.2021.0921